This is a recorded version of the webinar on Women and Bleeding: Challenges of Hemophilia Carriage, VWD, and Other Rare Bleeding Disorders that was presented live on February 11, 2015. Please scroll all the way down this page to view the archived webinar. 

This Webinar was made possible in part by an education grant from Bayer Healthcare Pharmaceuticals.

This program provides evidence-based, practical information on the signs and symptoms of bleeding disorders, specifically Hemophilia Carriage, VWD, and other rare bleeding disorders, in women and girls. It will discuss the prevalence of these symptoms, and describe the accurate evaluation of, including laboratory assessment of, and the clinical management of these bleeding disorders among women and girls for optimizing their quality of life. The discrete impact of these conditions on women and girls, as well as the best diagnostic tools, optimal therapies and treatment guidelines will be presented. Healthcare providers will also be introduced to the Hemophilia Federation of America’s approved mobile application as an important collaborative tool that they can put into the hands of their patients to help them more effectively track their bleeding.


Roshni Kulkarni, MD
Professor, Pediatric Hematology/Oncology
Director(Peds) MSU Center for Bleeding and Clotting Disorders
Department of Pediatrics and Human Development, Michigan State University 

Robert F. Sidonio, Jr., MD, MSc.
Assistant Professor of Pediatrics, Division of Hematology/Oncology
Associate Director of Hemostasis and Thrombosis
Aflac Cancer and Blood Disorders Center
Children's Healthcare of Atlanta/Emory University School of Medicine 

At the conclusion of this activity, learners should be able to:

  • Recognize the signs and symptoms of bleeding disorders in women, including Hemophilia Carriage, VWD and other rare bleeding disorders within the clinical setting
  • Determine protocols for evaluating underlying bleeding disorders in women
  • Describe the evaluation of bleeding disorders in women, including laboratory assessment
  • Explain current guidelines for the optimal treatment of women with hemophilia carriage, VWD and other rare bleeding disorders
  • Describe available tools to help women and girls effectively track their bleeding, including the Hemophilia Federation of America’s approved mobile application

This session is jointly provided by The Duke University Health System Department of Clinical Education & Professional School of Medicine and the Foundation for Women & Girls with Blood Disorders.